$0.83 EPS Expected for Henry Schein, Inc. (NASDAQ:HSIC) This Quarter

Brokerages forecast that Henry Schein, Inc. (NASDAQ:HSIC) will announce $0.83 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Eight analysts have issued estimates for Henry Schein’s earnings, with estimates ranging from $0.78 to $0.86. Henry Schein posted earnings per share of $1.04 in the same quarter last year, which would suggest a negative year over year growth rate of 20.2%. The company is scheduled to issue its next earnings report on Monday, August 5th.

According to Zacks, analysts expect that Henry Schein will report full year earnings of $3.45 per share for the current financial year, with EPS estimates ranging from $3.41 to $3.50. For the next fiscal year, analysts forecast that the business will post earnings of $3.77 per share, with EPS estimates ranging from $3.66 to $3.95. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover Henry Schein.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.04. Henry Schein had a return on equity of 18.35% and a net margin of 4.10%. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.36 billion. During the same quarter in the previous year, the firm posted $0.95 EPS. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year.

A number of research analysts recently issued reports on the company. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, May 7th. Guggenheim assumed coverage on Henry Schein in a research report on Wednesday, April 17th. They set a “buy” rating and a $72.00 price objective for the company. Robert W. Baird restated a “neutral” rating on shares of Henry Schein in a research report on Monday, March 25th. Finally, Cleveland Research restated a “hold” rating on shares of Henry Schein in a research report on Thursday, May 2nd. Seven research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $74.13.

In other Henry Schein news, Director Paul Brons sold 1,758 shares of Henry Schein stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $70.96, for a total transaction of $124,747.68. Following the sale, the director now owns 17,582 shares of the company’s stock, valued at approximately $1,247,618.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Steven Paladino sold 20,712 shares of Henry Schein stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $72.17, for a total value of $1,494,785.04. Following the sale, the chief financial officer now directly owns 166,233 shares in the company, valued at approximately $11,997,035.61. The disclosure for this sale can be found here. Insiders have sold a total of 49,668 shares of company stock worth $3,572,423 in the last ninety days. 1.06% of the stock is owned by company insiders.

Institutional investors have recently made changes to their positions in the business. Stephens Investment Management Group LLC raised its stake in Henry Schein by 3.8% during the 1st quarter. Stephens Investment Management Group LLC now owns 59,900 shares of the company’s stock valued at $3,601,000 after acquiring an additional 2,175 shares in the last quarter. Mn Services Vermogensbeheer B.V. raised its stake in shares of Henry Schein by 1.1% in the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 84,529 shares of the company’s stock worth $5,081,000 after buying an additional 900 shares in the last quarter. Headinvest LLC raised its stake in shares of Henry Schein by 100.0% in the 4th quarter. Headinvest LLC now owns 13,160 shares of the company’s stock worth $1,033,000 after buying an additional 6,580 shares in the last quarter. Bell Rock Capital LLC bought a new stake in shares of Henry Schein in the 1st quarter worth $581,000. Finally, Bessemer Group Inc. raised its stake in shares of Henry Schein by 1.8% in the 4th quarter. Bessemer Group Inc. now owns 23,991 shares of the company’s stock worth $1,885,000 after buying an additional 420 shares in the last quarter.

NASDAQ:HSIC opened at $69.90 on Friday. Henry Schein has a 12-month low of $56.58 and a 12-month high of $91.35. The firm has a market cap of $10.27 billion, a price-to-earnings ratio of 16.92, a P/E/G ratio of 2.41 and a beta of 0.82. The company has a quick ratio of 0.93, a current ratio of 1.65 and a debt-to-equity ratio of 0.34. The firm’s 50 day moving average is $68.55.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Article: What does RSI mean?

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.